Login or Register for interactive features
12345

R&D News: Researchers identify a way to produce liver-like cells from induced iPSCs


Researchers at the Massachusetts Institute of Technology (MIT), Rockefeller University and the Medical College of Wisconsin have identified a way to produce liver-like cells from induced pluripotent stem cells (iPSCs), which are made from body tissues rather than embryos; the liver-like cells can then be infected with hepatitis C.
R&D News: Researchers identify a way to produce liver-like cells from induced iPSCs

R&D News: Researchers discover the process leading to AML


Researchers at the University of California - Santa Barbara (UCSB) have discovered a molecular pathway that may explain how an acute myeloid leukemia (AML) develops.

The research team described how a certain mutation in DNA disrupts cellular function in patients with AML.
R&D News: Researchers discover the process leading to AML

R&D News: Defects in enzymes can severely alter a cell’s DNA sequences


In a new study, MIT biological engineers have found that defects in enzymes that control purines can severely alter a cell’s DNA sequences, which may explain why people who carry certain genetic variants of purine metabolic enzymes have a higher risk for some types of cancer.
R&D News: Defects in enzymes can severely alter a cell’s DNA sequences

R&D News: Leprosy pathogen evades critical vitamin D-dependent immune response


In a study, funded by the National Institutes of Health (NIH), a team of scientists at the University of California, Los Angeles (UCLA) has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.
R&D News: Leprosy pathogen evades critical vitamin D-dependent immune response

R&D News: Researchers identify origins of esophageal adenocarcinoma


In a study, supported by the National Cancer Institute (NCI), researchers at the Columbia University Medical Center (CUMC) have identified where and how esophageal adenocarcinoma (EAC) arises.

The study findings highlight possible targets for new clinical therapies.
R&D News: Researchers identify origins of esophageal adenocarcinoma

PJSC Ukrsotsbank to Outsource IT Processes to IBM

PJSC Ukrsotsbank, part of UniCredit Group, has decided to outsource its information technology (IT) systems and processes to IBM to improve customer service, increase performance efficiency and lower operational risk.
 

Boston Scientific Introduces TruePath CTO Device

Boston Scientific Corporation has introduced the TruePath CTO Device that is used to treat chronic total occlusions (complete blockages or CTOs) in peripheral arteries in the US.
 

Sanofi Q4 Net Sales Up 8.8%

Vaccine maker Sanofi has reported net sales of E8.5 billion for the fourth quarter of 2011, an increase of 8.8 percent, compared to E7.82 billion for the same period in 2010.
 

BP Q4 Profit Soars

BP has reported a profit of $7.77 billion for the fourth quarter of 2011, compared to $5.66 billion for the same period in 2010. The company's refining and marketing segment reported a record underlying pre-tax profit of $6 billion in 2011.
 

Genomic Health to Establish New Subsidiary

Genomic Health, a developer of genomic-based clinical laboratory services, is planning to establish a wholly owned genetics subsidiary in March 2012 with an investment of up to $20m over the next two years.
 

Suzuki and IE to Establish 50/50 JV

Suzuki Motor Corporation and Intelligent Energy (IE) of UK are planning to establish SMILE FC System Corporation (SMILE FC), a new 50/50 joint venture with an investment of JPY750m to develop and manufacture fuel cell systems.
 

GE Introduces New Gas Turbine Filtration Product

GE has introduced TS1000 coalescer, a new gas turbine filtration product that offers better plant performance and lower maintenance costs to customers operating power generation facilities in harsh conditions near coastal environments.
 

Technip Secures Two Contracts worth E100m

Technip, a provider of project management, engineering and construction services for the energy industry, has secured two contracts, worth approximately E100m, from Tullow Ghana for the Phase 1A of the Jubilee project.
 

Volvo Group Q4 Net Sales Up 18%

Sweden-based Volvo Group has reported net sales of SEK86.5 billion for the fourth quarter of 2011, an increase of 18 percent, compared to SEK73.39 billion for the same period in 2010.
The company’s operating income amounted to SEK6.95 billion for the fourth quarter of 2011, compared to SEK 5.51 billion for the same period in 2010.
Net interest expense in the fourth quarter was SEK522m, compared to SEK655m for the same period in 2010. In the third quarter of 2011 net interest expense amounted to SEK589m.
The income amounted to SEK4.79 billion for the fourth quarter of 2011, compared to SEK3.41 billion for the same period in 2010.
The tax expense in the fourth quarter amounted to SEK1.59 billion, compared to SEK1.07 billion for the same period in 2010.
For the full year of 2011, net sales were SEK310.4 billion, an increase of 17 percent, compared to SEK264.7 billion for 2010. Operating income was SEK 26.9 billion, compared to SEK18 billion for 2010.
Operating margin was a record 8.7 percent for 2011, compared to 6.8 percent in 2010.
Olof Persson, president and CEO, said: “If we review the full-year 2011, the Volvo Group generated the highest net sales, the best operating income and the highest operating margin to date. Net sales rose to SEK 310 billion (265), operating income improved to SEK 26.9 billion (18) and the operating margin was 8.7 percent (6.8). At the same time, the return on operating capital in the industrial operations rose to 28.8 percent and the return on shareholders’ equity in the group to 23.1 percent.”
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.
 

Boston Scientific Gets CE Mark Nod for Infinion 16 Lead

Medical devices developer Boston Scientific Corporation has received Conformite Europeenne (CE) Mark approval for the new Infinion 16 Percutaneous Lead for its Precision Plus spinal cord stimulator (SCS) system.
 

Featured Company

Red Hat, Inc.

Red Hat, Inc. (Red Hat) is principally engaged in the provision of enterprise-ready open source operating system platforms. It offers a wide range of open source software solutions including core enterprise operating system platform, Red Hat Enterprise Linux, enterprise middleware platform, JBoss Enterprise Middleware and other related Red Hat enterprise technologies.

The company\'s enterprise solutions are designed to address the requirements of various functionalities and performance standards and third-party computer hardware and software applications. It delivers these solutions through an integrated set of management services, Red Hat Network, JBoss Operations Network and JBoss Customer Support Portal. It offers and develops these solutions through its open source software development and licensing model on continuous basis.

Red Hat operates offices in over 55 worldwide locations. The company has strong global foot print in different parts of the world including Americas, EMEA and Asia Pacific regions. Red Hat is headquartered at North Carolina, in the United States.

The company reported revenues of (U.S. Dollars) USD 652.57 million during the fiscal year ended February 2009, an increase of 24.77% over 2008. The operating profit of the company was USD 82.52 million during the fiscal year 2009, an increase of 17.26% over 2008. The net profit of the company was USD 78.72 million during the fiscal year 2009, an increase of 2.68% over 2008.
Current Index Score Historical Index Score
  • Red Hat, Inc. is currently ranked 1 out of 35418 companies. This is in the top 0 percent of companies ranked in the index.
  • Red Hat, Inc. is currently ranked 1 out of 35419 included in the InfoGrok Company Index. This is the top 0 percent of companies.
  • User perception of the company stands at 50 percent. This differs 24  percent over the score attributed to the company by other scoring factors.

To learn more about our unique scoring methodology please click here

Surveys List

Product Development in the Pharmaceutical Industry
Product Development in the Energy Industry
Pharmaceutical Business and Financial Outlook Survey
Energy Business and Financial Outlook Survey
Energy Industry Salary Survey 2010/11
View All

Report Store

Report DetailsPublishedSingle Price Site PriceEnterprise Price
Zygo Corporation (ZIGO) - Financial and Strategic SWOT Analysis Review Dec-2011 $250.00$500.00$750.00
Starcomms PLC (STARCOMMS) - Financial and Strategic SWOT Analysis Review Dec-2011 $125.00$250.00$375.00
Sangoma Technologies Corporation (STC) - Financial and Strategic SWOT Analysis Review Dec-2011 $250.00$500.00$750.00
VanceInfo Technologies Inc. (VIT) - Financial and Strategic SWOT Analysis Review Dec-2011 $125.00$250.00$375.00
China Digital Licensing (Group) Limited (8175) - Financial and Strategic SWOT Analysis Review Dec-2011 $125.00$250.00$375.00
Gennum Corporation (GND) - Financial and Strategic SWOT Analysis Review Dec-2011 $250.00$500.00$750.00
     View All Reports

InfoGrok Company Index

Rank Company Score Up/Down
1Red Hat, Inc.74
1Covidien plc74
1Ocean Power Technologies, Inc.74
2Takeda Pharmaceutical Company Limited73
2BNP Paribas SA73
2Becton, Dickinson and Company73
3Adobe Systems Incorporated72
4Wal-Mart Stores, Inc.71
LinQ - Quality Market Research
LinQ Quality Market Research is a full-service market research institute specialized both, in qualit ...
Polarion Software
Innovative Application Lifecycle Management technology with thorough knowledge of Medical Device sta ...
LOMAPHARM®
Contract Manufacturing of Tablets, Film Tablets, Sugar coated Tablets, and Liquids including Aseptic ...
Pharmatest Services Ltd
Pharmatest Services Ltd is a full-service contract research organization specialized in translationa ...

Sentiment Scoring

Rate Red Hat, Inc.'s current performance and outlook using the gauges below. Each registered user can vote once per day.
Brand Strength:
0%
100%
Business Innovation:
0%
100%
Management Strength:
0%
100%
Overall Performance:
0%
100%


Latest Jobs

Job Title Category
Maintenance Technician Consumer

ICD Research Buy One Get One Free offer

ICD Research Buy One Get One Free offer on all construction content until January 1, 2012. Please note that the report of lesser value will be the one that is free. For details please click here

 Register
Here
  Company
Profiles
  Job
Search
 Suppliers
Directory

  Network Login:


Copyright ©2010 Progressive Innovations Ltd. Reproduction of material from any page on this domain without prior written permission is strictly prohibited.